Literature DB >> 11588588

Expression of beta-synuclein in normal human astrocytes.

K Tanji1, F Mori, S Nakajo, T Imaizumi, H Yoshida, T Hirabayashi, M Yoshimoto, K Satoh, H Takahashi, K Wakabayashi.   

Abstract

Although alpha- and beta-synucleins are expressed predominantly in presynaptic nerve terminals, recent studies have demonstrated that alpha-synuclein is also expressed in cultured astrocytes and oligodendrocytes. We determined whether beta-synuclein might be expressed in astrocytes. Beta-synuclein mRNA and protein were detected in normal human astrocytes in culture, and immunofluorescent staining showed that beta-synuclein protein was expressed within the cytoplasm and nucleus. Furthermore, beta-synuclein immunoreactivity was present in astrocytes, but not in oligodendrocytes, in normal human brain tissues. Ultrastructurally, beta-synuclein immunoreactivity was found in the cytoplasm of astrocytes, in association with the plasma membrane, ribosomes, rough endoplasmic reticulum and the nuclear outer membrane. The novel expression of beta-synuclein in astrocytes may provide an important insight about the role of this protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588588     DOI: 10.1097/00001756-200109170-00018

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  Alpha-synuclein expression modulates microglial activation phenotype.

Authors:  Susan A Austin; Angela M Floden; Eric J Murphy; Colin K Combs
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

2.  Molecular cloning, characterization and developmental expression of porcine beta-synuclein.

Authors:  Knud Larsen; Pernille Munk Frandsen; Lone Bruhn Madsen; Christian Bendixen
Journal:  Mol Biol Rep       Date:  2009-04-03       Impact factor: 2.316

Review 3.  β-Synuclein: An Enigmatic Protein with Diverse Functionality.

Authors:  Junna Hayashi; John A Carver
Journal:  Biomolecules       Date:  2022-01-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.